Lawal, Ismaheel OpeyemiAbubakar, Sofiullah O.Ndlovu, HonestMokoala, Kgomotso M.G.More, StuartSathekge, Mike Machaba2024-06-192024-05Lawal, I.O., Abubakar, S.O., Ndlovu, H. et al. Advances in Radioligand Theranostics in Oncology. Molecular Diagnosis & Therapy 28, 265–289 (2024). https://doi.org/10.1007/s40291-024-00702-4.1177-1062 (print)1179-2000 (online)10.1007/s40291-024-00702-4http://hdl.handle.net/2263/96534Please read abstract in the article.en© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024. The original publication is available at : https://link.springer.com/journal/40291.Lutetium-177 DOTATATE (177Lu-DOTATATE)Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA)Fibroblast activation protein (FAP)Chemokine receptor 4 (CXCR4)RadioligandTheranosticsOncologySDG-03: Good health and well-beingAdvances in radioligand theranostics in oncologyPostprint Article